Fecal Microbiota Transplantation & Hematologic Diseases

[Current Advances in the Fecal Microbiota Transplantation and Its Application in the Hematologic Diseases--Review].


Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.


Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.


Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.


Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.


Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.


Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.


The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.


Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota.


Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.


Microbiota modification in hematology: still at the bench or ready for the bedside?


Microbiota modification in hematology: still at the bench or ready for the bedside?


Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.


Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition.


Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.


Probable fidaxomicin-induced pancytopenia.


Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.


Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia.


Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.


Attenuation of immune-mediated bone marrow damage in conventionally housed mice.

Immune Thrombocytopenia Caused by Fecal Microbial Transplantation in a Patient With Severe Recurrent Clostridium difficile Infection.